Nuno Charro
Instituto Nacional de Saúde Dr. Ricardo Jorge
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nuno Charro.
Journal of Proteome Research | 2009
Isabel Carvalho-Oliveira; Nuno Charro; Jamil Aarbiou; Ruvalic M. Buijs-Offerman; Martina Wilke; Thomas Schettgen; Thomas Kraus; Mark K. Titulaer; Peter C. Burgers; Theo M. Luider; Deborah Penque; Bob J. Scholte
Combined results from laser capture microdissection of mouse airway epithelial cells followed by high power (MALDI-FTICR) MS, and fluorescent two-dimensional gel elctrophoresis (2D-DIGE) of the whole lung, allowed us to identify proteins differentially expressed after naphthalene induced airway injury. Further, we discovered several novel aspects of Cystic Fibrosis (CF) lung pathology in an F508del-Cftr mouse model using this approach. The combined MALDI-FTICR-MS and 2D-DIGE data show that lung carbonyl reductase (CBR2), involved in prostaglandin metabolism, converting PGE2 to PGF2alpha, is localized to airway cells and is reduced 2-fold in mutant mice compared to normal, both before and after challenge. Further, we observe a downregulation of two key enzymes of retinoic acid metabolism after injury, which is more pronounced in CF mutant mice. These data show that state-of-the-art proteomics can be used to evaluate airway injury in small cell samples. Further, the results suggest the involvement of prostaglandin and retinoic acid metabolism in the abnormal responses of CF mutant mice to injury.
Journal of Proteome Research | 2010
Brian L. Hood; Jelena Grahovac; Melanie S. Flint; Mai Sun; Nuno Charro; Dorothea Becker; Alan Wells; Thomas P. Conrads
Gaining insights into the molecular events that govern the progression from melanoma in situ to advanced melanoma and understanding how the local microenvironment at the melanoma site influences this progression are two clinically pivotal aspects that to date are largely unexplored. In an effort to identify key regulators of the crosstalk between melanoma cells and the melanoma-skin microenvironment, primary and metastatic human melanoma cells were seeded into skin organ cultures (SOCs) and grown for two weeks. Melanoma cells were recovered from SOCs by laser microdissection and whole-cell tryptic digests were analyzed by nanoflow liquid chromatography-tandem mass spectrometry. The differential protein abundances were calculated by spectral counting, the results of which provides evidence that cell-matrix and cell-adhesion molecules that are upregulated in the presence of these melanoma cells recapitulate proteomic data obtained from comparative analysis of human biopsies of invasive melanoma and a tissue sample of adjacent, noninvolved skin. This concordance demonstrates the value of SOCs for conducting proteomic investigations of the melanoma microenvironment.
Journal of Proteomics | 2012
Bruno M. Alexandre; Nuno Charro; Josip Blonder; Carlos Lopes; Pilar Azevedo; António Bugalho de Almeida; King C. Chan; DaRue A. Prieto; Haleem J. Issaq; Timothy D. Veenstra; Deborah Penque
Structural and metabolic alterations in erythrocytes play an important role in the pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). Whether these dysfunctions are related to the modulation of erythrocyte membrane proteins in patients diagnosed with COPD remains to be determined. Herein, a comparative proteomic profiling of the erythrocyte membrane fraction isolated from peripheral blood of smokers diagnosed with COPD and smokers with no COPD was performed using differential (16)O/(18)O stable isotope labeling. A total of 219 proteins were quantified as being significantly differentially expressed within the erythrocyte membrane proteomes of smokers with COPD and healthy smokers. Functional pathway analysis showed that the most enriched biofunctions were related to cell-to-cell signaling and interaction, hematological system development, immune response, oxidative stress and cytoskeleton. Chorein (VPS13A), a cytoskeleton related protein whose defects had been associated with the presence of cell membrane deformation of circulating erythrocytes was found to be down-regulated in the membrane fraction of erythrocytes obtained from COPD patients. Methemoglobin reductase (CYB5R3) was also found to be underexpressed in these cells, suggesting that COPD patients may be at higher risk for developing methemoglobinemia. This article is part of a Special Issue entitled: Integrated omics.
Journal of Allergy and Therapy | 2012
Tânia Simões; Nuno Charro; Bruno M. Alexandre; Deborah Penque
Asthma and chronic obstructive pulmonary disease (COPD) are major causes of mortality and morbidity worldwide. The current state-of-art diagnosis and management schemes are suboptimal for both diseases as the incidence of asthma has risen by 250% over the last two decades and COPD is estimated to become the third leading cause of death worldwide within the next decade. Additionally, these diseases represent a very important threat to global economies in direct and indirect medical costs and lost working days [1,2]. Asthma is a chronic inflammatory disorder of the airways associated with airway hyperresponsiveness that leads to recurrent episodes of wheezing, breathlessness, chest tightness and coughing. These episodes are usually associated with widespread, but variable, airflow obstruction within the lung [1]. Chronic airflow obstruction is also characteristic of COPD but, in contrast to asthma, is not fully reversible, even under the action of bronchodilators, and is usually progressive. A combination of small airway disease -obstructive bronchiolitis and parenchymal destruction emphysema, leads to COPD clinical manifestation [2]. A number of factors influence a person’s risk of developing these lung diseases, which include host factors, primarily genetic, and environmental factors, such as allergens and tobacco smoke in asthma and COPD, respectively [1-3].
Biochimie | 2011
Pedro M.F. Sousa; Sara T.N. Silva; Brian L. Hood; Nuno Charro; João N. Carita; Fátima Vaz; Deborah Penque; Thomas P. Conrads; Ana M.P. Melo
Journal of Proteomics | 2011
Nuno Charro; Brian L. Hood; Daniel Faria; Paula Pacheco; Pilar Azevedo; Carlos Lopes; António Bugalho de Almeida; Francisco M. Couto; Thomas P. Conrads; Deborah Penque
Journal of Proteomics | 2011
Tânia Simões; Nuno Charro; Josip Blonder; Daniel Faria; Francisco M. Couto; King C. Chan; Timothy J. Waybright; Haleem J. Isaaq; Timothy D. Veenstra; Deborah Penque
1st International Symposium on Profiling (ISPROF), 2-4 september 2013 | 2013
Fátima Vaz; Nuno Charro; Anabela Morais; João Lavinha; Deborah Penque
EuPA/BSPR 2012 Scientific Conference - New Horizons and Applications for Proteomics, 9-12 July 2012 | 2012
Nuno Charro; Fátima Vaz; Anabela Morais; João Lavinha; Deborah Penque
13º Congresso Nacional de Pediatria, Sociedade Portuguesa de Pediatria, 11-13 Outubro 2012 | 2012
João Lavinha; Nuno Charro; Fátima Vaz; Anabela Morais; Deborah Penque